• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10620
Device Problems Fracture (1260); Failure to Advance (2524); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/13/2024
Event Type  malfunction  
Manufacturer Narrative
E1: initial reporter phone: (b)(6).
 
Event Description
It was reported that a stent fracture occurred.The occluded target lesion was located in the tortuous and calcified left anterior descending artery.A 3.50 x 24 synergy drug-eluting stent was advanced for treatment.However, during the procedure, the stent failed to cross the lesion and fractured.The procedure was completed with a different device.No patient complications were reported, and the patient was stable.
 
Manufacturer Narrative
B5 - describe event or problem: updated to include new information obtained h6 - coding updated per new information obtained.E1: initial reporter phone: (b)(6).
 
Event Description
It was reported that a stent fracture occurred.The occluded target lesion was located in the tortuous and calcified left anterior descending artery.A 3.50 x 24 synergy drug-eluting stent was advanced for treatment.However, during the procedure, the stent failed to cross the lesion and fractured.The procedure was completed with a different device.No patient complications were reported, and the patient was stable.It was further reported that stenosed target lesion was 60-70%.Following pre-dilatation of a balloon, the stent was deployed with the same size standard pressure deployment.However, there was no indication that the stent broke into two pieces.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19035111
MDR Text Key339279741
Report Number2124215-2024-20185
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number10620
Device Catalogue Number10620
Device Lot Number0030756746
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/07/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age69 YR
Patient SexMale
Patient Weight72 KG
-
-